OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS)
OrthoPediatrics (Nasdaq: KIDS) announced its participation and Emerald-Level sponsorship at the 20th Annual International Pediatric Orthopaedic Symposium (IPOS) in Orlando, Florida, from December 3-7. The event, expecting over 500 pediatric orthopedic surgeons, will feature the company's exhibition booths showcasing their full product suite, including the new Enabling Technology division with 7D, 3-D Side, and Specialty Bracing division (OPSB).
The company will host several educational sessions, including discussions on rigid tibial nailing, bioresorbable implants, career launching, and spica cast usage. A pre-course innovation session focusing on creative solutions is also scheduled.
OrthoPediatrics (Nasdaq: KIDS) ha annunciato la sua partecipazione e sponsorizzazione di livello Emerald al 20° Simposio Internazionale di Ortopedia Pediatrica (IPOS) che si terrà a Orlando, Florida, dal 3 al 7 dicembre. L'evento, che prevede la partecipazione di oltre 500 chirurghi ortopedici pediatrici, presenterà gli stand espositivi dell'azienda che mostreranno l'intera gamma dei loro prodotti, compresa la nuova divisione Tecnologie Abilitanti con divisioni 7D, 3-D Side e Speciality Bracing (OPSB).
L'azienda organizzerà diverse sessioni educative, tra cui discussioni sulla fissazione tibiale rigida, impianti bioassorbibili, avvio della carriera e utilizzo del gesso spica. È prevista anche una sessione di innovazione pre-corso incentrata su soluzioni creative.
OrthoPediatrics (Nasdaq: KIDS) anunció su participación y patrocinio de nivel Emerald en el 20º Simposio Internacional de Ortopedia Pediátrica (IPOS) en Orlando, Florida, del 3 al 7 de diciembre. Se espera que el evento atraiga a más de 500 cirujanos ortopédicos pediátricos y contará con los stands de exhibición de la compañía que mostrarán su gama completa de productos, incluida la nueva división de Tecnología Habilitadora con las divisiones 7D, 3-D Side y Specialty Bracing (OPSB).
La empresa llevará a cabo varias sesiones educativas, incluidas discusiones sobre clavos tibiales rígidos, implantes bioresorbibles, lanzamiento de carreras y uso de yeso espica. También está programada una sesión de innovación previa al curso centrada en soluciones creativas.
OrthoPediatrics (Nasdaq: KIDS)는 플로리다주 올랜도에서 12월 3일부터 7일까지 열리는 제20회 국제 소아 정형외과 심포지엄(IPOS)에 참가하고 에메랄드 수준의 후원한다는 소식을 전했습니다. 이 행사에는 500명 이상의 소아 정형외과 의사가 참석할 것으로 예상되며, 회사의 전 제품군을 선보일 전시 부스가 마련됩니다. 여기에는 7D, 3-D Side, Specialty Bracing 부서를 포함한 새로운 기술 지원 부서도 포함됩니다(OPSB).
회사는 강직 경골 고정, 생분해성 임플란트, 경력 시작 및 스피카 캐스트 사용에 대한 논의를 포함한 여러 교육 세션을 주최합니다. 창의적인 솔루션에 중점을 둔 사전 과정 혁신 세션도 예정되어 있습니다.
OrthoPediatrics (Nasdaq: KIDS) a annoncé sa participation et son parrainage de niveau Emerald au 20ème Symposium International d'Orthopédie Pédiatrique (IPOS) qui se tiendra à Orlando, en Floride, du 3 au 7 décembre. L'événement, qui devrait réunir plus de 500 chirurgiens orthopédiques pédiatriques, présentera les stands d'exposition de l'entreprise qui mettront en avant l'ensemble de leur gamme de produits, y compris la nouvelle division de Technologie de Soutien avec les divisions 7D, 3-D Side et Spécialité d’Orthèses (OPSB).
L'entreprise organisera plusieurs sessions éducatives, dont des discussions sur la clouage tibial rigide, les implants bioresorbables, le lancement de carrière et l'utilisation de plâtres spica. Une session d'innovation préalable au cours axée sur des solutions créatives est également prévue.
OrthoPediatrics (Nasdaq: KIDS) gab seine Teilnahme und das Emerald-Level-Sponsoring am 20. Internationalen Symposium für Kinderorthopädie (IPOS) in Orlando, Florida, vom 3. bis 7. Dezember bekannt. Bei der Veranstaltung, zu der über 500 pädiatrische Orthopäden erwartet werden, wird das Unternehmen an seinen Messeständen seine gesamte Produktpalette präsentieren, einschließlich der neuen Abteilung für unterstützende Technologien mit 7D-, 3D-Seiten- und Spezialschienenabteilungen (OPSB).
Das Unternehmen wird mehrere Schulungssitzungen ausrichten, darunter Diskussionen über starre tibiale Nagelung, bioabsorbierbare Implantate, Karriereaufbau und die Verwendung von Spica-Gipsverbänden. Eine Innovationssitzung vor dem Kurs mit Fokus auf kreative Lösungen ist ebenfalls geplant.
- None.
- None.
Continues IPOS Corporate Partnership as Emerald-Level Sponsor
WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its continued support of the event as an Emerald-Level sponsor. IPOS, a branch of the Pediatric Orthopedic Society of North America (POSNA), is a leading educational meeting for pediatric orthopedic surgeons. Over 500 pediatric orthopedic surgeons are registered to attend the meeting from December 3-7, in Orlando, Florida.
“This year marks the 20th Annual IPOS meeting, and I couldn’t be prouder of our partnership with this surgical society, and our participation in this meeting,” said David Bailey, President and CEO of OrthoPediatrics. “IPOS is a great educational opportunity for early career surgeons, and our team is excited to connect with customers and share hands-on learning experiences with our new and innovative products. I’m especially excited to introduce our new Enabling Technology division as well as highlight all the great work we are doing in non-operative care through OPSB Specialty Bracing.”
In addition to the exhibition booths (#1 - 3), wherein the Company will highlight their full suite of products, and feature its new Enabling Technology division with 7D, 3-D Side and the new Specialty Bracing division (OPSB), the Company is hosting several educational experiences for surgeons and other allied health professionals. OrthoPediatrics IPOS 2024 Events include:
Pre-course
- Innovation – Bringing Creative Solutions from Ideas to Reality
Tuesday, December 3, 2024, 6:30 – 7:45pm ET
Industry Spotlight Sessions
- Rigid Tibial Nailing in the Skeletally Immature Patient: What We’ve Learned So Far
Wednesday, December 4, 2024, 10:35am ET
- The Future is Bioresorbable: Innovative Implant Materials in Pediatrics
Wednesday, December 4, 2024, 4:05pm ET
- Launching Your Surgical Career: Essential Steps to Start Strong
Wednesday, December 4, 2024, 4:05pm ET
- Is it Possible to Minimize Spica Cast Usage?
Thursday, December 5, 2024, 10:35am ET
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
When and where is OrthoPediatrics (KIDS) hosting events at IPOS 2024?
What new divisions will OrthoPediatrics (KIDS) showcase at IPOS 2024?
How many surgeons are expected to attend IPOS 2024 where OrthoPediatrics (KIDS) is presenting?
What educational sessions is OrthoPediatrics (KIDS) hosting at IPOS 2024?
